PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972965

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972965

Immune Repertoire Sequencing Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED: March 6, 2026

PAGES: 192 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global Immune Repertoire Sequencing Market is steadily gaining momentum as scientific advancements in genomics and immunology continue to transform modern healthcare. Immune repertoire sequencing refers to advanced sequencing technologies that analyze the diversity of B-cell and T-cell receptors within the adaptive immune system. By examining the composition and variation of immune receptors, researchers are able to gain deeper insights into immune responses to diseases, infections, and therapeutic interventions.

This technology has emerged as a powerful tool for understanding immune system behavior and has become increasingly valuable in areas such as cancer immunotherapy, vaccine development, autoimmune disease research, and biomarker discovery. With the growing emphasis on precision medicine and targeted therapies, immune repertoire sequencing is being widely adopted by research institutions, pharmaceutical companies, and diagnostic laboratories around the world.

The continuous evolution of next-generation sequencing platforms and advanced bioinformatics tools has further enhanced the accuracy and scalability of immune repertoire analysis. As a result, the technology is playing an increasingly important role in clinical research and therapeutic innovation.

Market Insights

The Immune Repertoire Sequencing Market is projected to reach USD 354.6 billion by 2026 and is anticipated to grow to USD 582.5 billion by 2033, registering a compound annual growth rate (CAGR) of 4.80% during the forecast period. This growth is primarily attributed to the increasing demand for advanced immune profiling techniques and the expanding use of sequencing technologies in medical research.

Immune repertoire sequencing provides comprehensive data on immune cell diversity and receptor distribution, enabling scientists to understand immune responses at a molecular level. This information is crucial for developing new therapeutic strategies, especially in fields such as oncology and immunology.

The rising integration of bioinformatics software with sequencing platforms is also improving the efficiency of immune data analysis. Researchers can now process large volumes of sequencing data more quickly, enabling faster discoveries and improved research outcomes. As technology continues to advance, immune repertoire sequencing is expected to become an essential component of next-generation diagnostic and research workflows.

Market Drivers

Several factors are driving the expansion of the immune repertoire sequencing market. One of the major growth drivers is the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases. These conditions require advanced diagnostic tools and deeper insights into immune system behavior, which immune repertoire sequencing can provide.

The growing popularity of immunotherapy is another key factor contributing to market growth. Treatments such as immune checkpoint inhibitors and CAR-T cell therapies depend heavily on detailed immune profiling. Immune repertoire sequencing allows researchers to monitor immune responses and identify specific receptor patterns that influence treatment outcomes.

Technological progress in sequencing platforms has also significantly improved the efficiency and affordability of immune sequencing methods. Modern next-generation sequencing technologies offer higher throughput, faster processing times, and improved accuracy, making them increasingly accessible to research organizations and clinical laboratories.

Additionally, government funding and private investment in genomics research are supporting the adoption of immune sequencing technologies. Academic institutions and biotechnology companies are investing heavily in immunological research, which is further accelerating market development.

Business Opportunities

The Immune Repertoire Sequencing Market offers substantial growth opportunities for biotechnology firms, pharmaceutical companies, and diagnostic developers. As healthcare systems move toward personalized medicine, immune profiling technologies are expected to become central to disease diagnosis and treatment planning.

One of the most promising opportunities lies in cancer immunotherapy research. Immune repertoire sequencing enables researchers to identify tumor-specific immune responses and evaluate how patients respond to immunotherapies. This information can guide the development of more effective and targeted cancer treatments.

Another major opportunity exists in biomarker discovery. Immune sequencing technologies can identify unique immune signatures associated with various diseases. These biomarkers can help clinicians diagnose conditions earlier, monitor disease progression, and predict treatment responses more accurately.

Furthermore, the integration of artificial intelligence and machine learning with immune sequencing data analysis is opening new possibilities for research and clinical applications. Advanced data analytics platforms are helping scientists interpret complex immune datasets and uncover patterns that may lead to breakthrough therapies.

Regional Analysis

North America holds a leading position in the global immune repertoire sequencing market due to its advanced healthcare infrastructure, strong biotechnology industry, and extensive research activities. The region also benefits from significant investments in genomics research and the presence of major sequencing technology providers.

Europe is another important market, supported by increasing research collaborations and government initiatives focused on precision medicine. Countries in the region are actively investing in genomic sequencing programs and immunology research, which is driving the adoption of immune repertoire sequencing technologies.

The Asia Pacific region is expected to witness notable growth during the forecast period. Rapid development in biotechnology, increasing healthcare investments, and expanding research capabilities are contributing to market growth in countries such as China, Japan, and India. The presence of emerging biotechnology companies and contract research organizations is further strengthening the regional market.

Latin America and the Middle East & Africa are gradually adopting advanced sequencing technologies as healthcare infrastructure improves. Although these regions currently account for smaller shares of the global market, increasing awareness of genomic medicine and expanding research capabilities are expected to support future growth.

Key Players

Illumina Inc.
Thermo Fisher Scientific
PacBio
CD Genomics
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
BGI Group Guangdong
Takara Bio, Inc.
Adaptive Biotechnologies
Juno Therapeutics
Atreca, Inc.
irepertoire, Inc.

These companies are focusing on technological innovation, strategic partnerships, and research collaborations to strengthen their position in the global immune repertoire sequencing market. Continuous product development and expansion of sequencing platforms are helping these organizations address the evolving needs of researchers and healthcare providers.

Market Segmentation

By Product Type

Assay Kits
Software
Instruments

By Subject Type

Human
Mouse

By Application

Biomarker Discovery
Autoimmune Diseases
Cancer Immunotherapy

By End User

Diagnostic Labs
Pharmaceuticals Companies
Institutes

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Immune Repertoire Sequencing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Immune Repertoire Sequencing Market Outlook, 2020-2033

3.1. Global Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Assay Kits
- 3.1.2. Software
- 3.1.3. Instruments
3.2. Global Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 3.2.1. Human
- 3.2.2. Mouse
3.3. Global Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.3.1. Biomarker Discovery
- 3.3.2. Autoimmune Diseases
- 3.3.3. Cancer Immunotherapy
3.4. Global Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Diagnostic Labs
- 3.4.2. Pharmaceuticals Companies
- 3.4.3. Institutes
3.5. Global Immune Repertoire Sequencing Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Immune Repertoire Sequencing Market Outlook, 2020-2033

4.1. North America Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Assay Kits
- 4.1.2. Software
- 4.1.3. Instruments
4.2. North America Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 4.2.1. Human
- 4.2.2. Mouse
4.3. North America Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.3.1. Biomarker Discovery
- 4.3.2. Autoimmune Diseases
- 4.3.3. Cancer Immunotherapy
4.4. North America Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Diagnostic Labs
- 4.4.2. Pharmaceuticals Companies
- 4.4.3. Institutes
4.5. North America Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 4.5.2. U.S. Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 4.5.3. U.S. Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 4.5.4. U.S. Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 4.5.6. Canada Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 4.5.7. Canada Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 4.5.8. Canada Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Immune Repertoire Sequencing Market Outlook, 2020-2033

5.1. Europe Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Assay Kits
- 5.1.2. Software
- 5.1.3. Instruments
5.2. Europe Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 5.2.1. Human
- 5.2.2. Mouse
5.3. Europe Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.3.1. Biomarker Discovery
- 5.3.2. Autoimmune Diseases
- 5.3.3. Cancer Immunotherapy
5.4. Europe Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Diagnostic Labs
- 5.4.2. Pharmaceuticals Companies
- 5.4.3. Institutes
5.5. Europe Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.2. Germany Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.3. Germany Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.4. Germany Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.6. Italy Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.7. Italy Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.8. Italy Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.9. France Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.10. France Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.11. France Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.12. France Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.14. U.K. Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.15. U.K. Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.16. U.K. Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.18. Spain Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.19. Spain Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.20. Spain Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.22. Russia Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.23. Russia Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.24. Russia Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 5.5.26. Rest of Europe Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 5.5.27. Rest of Europe Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 5.5.28. Rest of Europe Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Immune Repertoire Sequencing Market Outlook, 2020-2033

6.1. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Assay Kits
- 6.1.2. Software
- 6.1.3. Instruments
6.2. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 6.2.1. Human
- 6.2.2. Mouse
6.3. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.3.1. Biomarker Discovery
- 6.3.2. Autoimmune Diseases
- 6.3.3. Cancer Immunotherapy
6.4. Asia Pacific Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Diagnostic Labs
- 6.4.2. Pharmaceuticals Companies
- 6.4.3. Institutes
6.5. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.2. China Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.3. China Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.4. China Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.6. Japan Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.7. Japan Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.8. Japan Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.10. South Korea Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.11. South Korea Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.12. South Korea Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 6.5.13. India Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.14. India Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.15. India Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.16. India Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.18. Southeast Asia Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.19. Southeast Asia Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.20. Southeast Asia Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 6.5.22. Rest of SAO Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 6.5.23. Rest of SAO Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 6.5.24. Rest of SAO Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Immune Repertoire Sequencing Market Outlook, 2020-2033

7.1. Latin America Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Assay Kits
- 7.1.2. Software
- 7.1.3. Instruments
7.2. Latin America Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 7.2.1. Human
- 7.2.2. Mouse
7.3. Latin America Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.3.1. Biomarker Discovery
- 7.3.2. Autoimmune Diseases
- 7.3.3. Cancer Immunotherapy
7.4. Latin America Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Diagnostic Labs
- 7.4.2. Pharmaceuticals Companies
- 7.4.3. Institutes
7.5. Latin America Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 7.5.2. Brazil Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 7.5.3. Brazil Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 7.5.4. Brazil Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 7.5.6. Mexico Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 7.5.7. Mexico Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 7.5.8. Mexico Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 7.5.10. Argentina Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 7.5.11. Argentina Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 7.5.12. Argentina Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 7.5.14. Rest of LATAM Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 7.5.15. Rest of LATAM Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 7.5.16. Rest of LATAM Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Immune Repertoire Sequencing Market Outlook, 2020-2033

8.1. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Assay Kits
- 8.1.2. Software
- 8.1.3. Instruments
8.2. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Subject Type, Value (US$ Bn), 2020-2033
- 8.2.1. Human
- 8.2.2. Mouse
8.3. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.3.1. Biomarker Discovery
- 8.3.2. Autoimmune Diseases
- 8.3.3. Cancer Immunotherapy
8.4. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Diagnostic Labs
- 8.4.2. Pharmaceuticals Companies
- 8.4.3. Institutes
8.5. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 8.5.2. GCC Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 8.5.3. GCC Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 8.5.4. GCC Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 8.5.6. South Africa Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 8.5.7. South Africa Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 8.5.8. South Africa Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 8.5.10. Egypt Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 8.5.11. Egypt Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 8.5.12. Egypt Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 8.5.14. Nigeria Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 8.5.15. Nigeria Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 8.5.16. Nigeria Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Immune Repertoire Sequencing Market Outlook, by Product Type, 2020-2033
- 8.5.18. Rest of Middle East Immune Repertoire Sequencing Market Outlook, by Subject Type, 2020-2033
- 8.5.19. Rest of Middle East Immune Repertoire Sequencing Market Outlook, by Application, 2020-2033
- 8.5.20. Rest of Middle East Immune Repertoire Sequencing Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Illumina Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. Thermo Fisher Scientific
- 9.4.3. PacBio
- 9.4.4. CD Genomics
- 9.4.5. Agilent Technologies, Inc.
- 9.4.6. F. Hoffmann-La Roche Ltd.
- 9.4.7. BGI Group Guangdong
- 9.4.8. Takara Bio, Inc.
- 9.4.9. Adaptive Biotechnologies
- 9.4.10. Juno Therapeutics